Form 4: Guardant Health CIO Executes RSU Vesting Transaction

Chief Information Officer Kumud Kalia acquired 638 shares of Guardant Health common stock via RSU vesting, with 314 shares withheld for taxes.

Summary

• Reporting person Kumud Kalia, Chief Information Officer of Guardant Health, Inc., acquired 638 shares of common stock upon the vesting of restricted stock units (RSUs).
• The company withheld 314 shares at a price of $129.82 per share to satisfy tax withholding obligations.
• Following these transactions, the reporting person holds 41,414 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents routine equity compensation management rather than a strategic or operational shift.

Positives

• The transaction reflects the standard vesting of equity compensation, indicating ongoing alignment between executive interests and shareholder value.

Negatives

• None identified; this is a routine administrative transaction related to equity compensation.

Risks

• None identified; this is a routine administrative transaction related to equity compensation.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory disclosure for executive equity compensation and does not signal a change in corporate strategy or market outlook.

Comparison to Industry Standards

• The transaction follows standard industry practices for executive compensation and tax withholding protocols.
• The vesting schedule is consistent with typical equity incentive plans for publicly traded biotechnology companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity vesting event.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units